Filtros de búsqueda

Lista de obras de Jan van Lunzen

A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine

artículo científico publicado en 2008

Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCG ⬇️

artículo científico publicado el 19 de enero de 2012

Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events

artículo científico publicado en 2012

Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

artículo científico publicado en 2013

Brief Report: Increased Frequency of CD39+ CD56bright Natural Killer Cells in HIV-1 Infection Correlates With Immune Activation and Disease Progression

artículo científico publicado en 2016

Brief Report: Switch to Ritonavir-Boosted Atazanavir Plus Raltegravir in Virologically Suppressed Patients With HIV-1 Infection: A Randomized Pilot Study

artículo científico publicado en 2015

CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression

artículo científico publicado en 2014

CMV specific cytokine release assay in whole blood is optimized by combining synthetic CMV peptides and toll like receptor agonists

artículo científico publicado en 2014

Calculation of Direct Antiretroviral Treatment Costs and Potential Cost Savings by Using Generics in the German HIV ClinSurv Cohort ⬇️

artículo científico publicado el 9 de septiembre de 2011

Cd32 Expression of Different Memory T Cell Subpopulations in the Blood and Lymph Nodal Tissue of Hiv Patients and Healthy Controls Correlates with Immune Activation

artículo científico publicado en 2017

Circulating CXCR5+CXCR3+PD-1lo Tfh-like cells in HIV-1 controllers with neutralizing antibody breadth

artículo científico publicado en 2017

Clinical Outcome of HIV-Infected Patients with Discordant Virological and Immunological Response to Antiretroviral Therapy ⬇️

artículo científico publicado el 8 de diciembre de 2010

Comprehensive Analysis of Frequency and Phenotype of T Regulatory Cells in HIV Infection: CD39 Expression of FoxP3+T Regulatory Cells Correlates with Progressive Disease ⬇️

artículo científico publicado el 3 de noviembre de 2010

Cost of Illness of HIV Patients under Anteretroviral Therapy in Germany - Results of the 48-Week Interim Analysis of the Prospective Multicentre Observational Study 'CORSAR'

artículo científico publicado en 2014

Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma

artículo científico publicado en 2009

Current hemoglobin levels are more predictive of disease progression than hemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV type 1 infection

artículo científico publicado en 2007

Decline in esophageal candidiasis and use of antimycotics in European patients with HIV.

artículo científico publicado en 2005

Decreased frequency of CD73+CD8+ T cells of HIV-infected patients correlates with immune activation and T cell exhaustion ⬇️

artículo científico publicado el 24 de mayo de 2013

Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration

artículo científico publicado en 2003

Does HIV-1 tropism change in patients during virological suppressive therapy?

article

Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?

article

Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patients

artículo científico publicado en 2014

Down-regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progression

artículo científico publicado en 2017

Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial).

artículo científico publicado en 2002

Efficacy and safety of TDF/FTC-containing first-line HAART in clinical practice – 2-year data from the German Outpatient Cohort

article

Efficacy and safety of TDF/FTC-containing, first-line HAART in clinical practice: 3-year data from the German outpatient cohort

article

Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48.

artículo científico publicado en 2008

Efficacy and tolerability of darunavir/r 600/100 mg bid in treatment-experienced patients: 48-week data from a German outpatient cohort.

artículo científico publicado en 2010

Epidemiologically linked transmission of HIV-1 illustrates the impact of host genetics on virological outcome

artículo científico publicado en 2009

Expansion of HIV-specific T follicular helper cells in chronic HIV infection

artículo científico publicado en 2012

Expansion of pre-existing, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infection

artículo científico publicado en 2002

From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany

artículo científico publicado en 2015

Functional Characterization of HLA-G+ Regulatory T Cells in HIV-1 Infection ⬇️

artículo científico publicado el 31 de enero de 2013

Gene therapy strategies: can we eradicate HIV?

artículo científico publicado en 2011

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

artículo científico publicado en 2014

HIV-induced immune activation: pathogenesis and clinical relevance - summary of a workshop organized by the German AIDS Society (DAIG e.v.) and the ICH Hamburg, Hamburg, Germany, November 22, 2008

artículo científico publicado en 2010

HIV-related non-Hodgkin's lymphoma among European AIDS patients. AIDS in Europe Study Group. AIDS in Europe Study Group

article

Hepatitis E virus infections in HIV-infected patients in Ghana and Cameroon

artículo científico publicado en 2013

High HIV prevalence among children presenting for general consultation in rural Cameroon

artículo científico publicado en 2014

High proportion of HIV late presenters at an academic tertiary care center in northern Germany confirms the results of several cohorts in Germany: time to put better HIV screening efforts on the national agenda?

artículo científico publicado en 2016

History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change

artículo científico publicado en 2010

Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study

artículo científico publicado en 2014

How will CCR5 antagonists influence the recommendations for the antiretroviral treatment of HIV-1 infection.

artículo científico publicado en 2007

IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection

artículo científico publicado en 2010

Immune activation despite suppressive highly active antiretroviral therapy is associated with higher risk of viral blips in HIV-1-infected individuals

artículo científico publicado en 2014

Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection

artículo científico publicado en 2006

Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients

artículo científico publicado en 2008

Improved Treatment for Primary HIV Infection by Interferon-Alfa Therapy? Does HCV Treatment in HIV/HCV Coinfected Patients Help Us to Test This Hypothesis? ⬇️

artículo científico publicado el 9 de abril de 2013

Incidence of abacavir hypersensitivity reactions in euroSIDA.

artículo científico

Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype

artículo científico publicado en 2016

Intensification of background antiretroviral therapy with abacavir during low-level failure may restore optimal suppression.

artículo científico publicado en 2000

International AIDS Society global scientific strategy: towards an HIV cure 2016.

scientific article published on 11 July 2016

Is there Emergence of Clinical HBV Resistance Under Long-Term HBV Combination Therapy? A Challenging Case Report ⬇️

artículo científico publicado el 29 de julio de 2010

Linker-Region Modified Derivatives of the Deoxyhypusine Synthase Inhibitor CNI-1493 Suppress HIV-1 Replication

artículo científico publicado en 2016

Low SAMHD1 expression following T-cell activation and proliferation renders CD4+ T cells susceptible to HIV-1.

artículo científico publicado en 2015

Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement

artículo científico publicado en 2014

Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy

artículo científico publicado en 1999

MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands

artículo científico publicado en 2007

Mycotic brain abscess caused by opportunistic reptile pathogen

artículo científico publicado en 2005

O331 Patterns of viral suppression on cART as predictors of uncontrolled viremia after starting a new antiretroviral after 1 January 2003

O423 Risk of new AIDS-defining events in patients with advanced immunodeficiency during suppressive HAART: results from the German ClinSurv cohort

article

Once-daily dolutegravir is superior to once-daily darunavir/ritonavir in treatment-naïve HIV-1-positive individuals: 96 week results from FLAMINGO

artículo científico publicado en 2014

Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study

artículo científico publicado en 2015

Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study

artículo científico publicado en 2014

Parallel assessment of Th17 cell frequencies by surface marker co-expression versus ex vivo IL-17 production in HIV-1 infection

artículo científico publicado en 2015

Patient-adapted, specific activation of HIV-1 by customized TAL effectors (TALEs), a proof of principle study

artículo científico publicado en 2015

Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy

artículo científico publicado en 2005

Personalizing humanized mice with cells obtained from an HIV post treatment controller

article

Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients

artículo científico publicado en 2010

Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study

artículo científico publicado en 2013

Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patients

artículo científico publicado en 2010

Primary HIV infection presenting as haemolytic crisis in a patient with previously undiagnosed glucose 6-phosphate dehydrogenase deficiency

artículo científico publicado en 2008

Quality of T-cell responses versus reduction in viral load: results from an exploratory phase II clinical study of Vacc-4x, a therapeutic HIV vaccine

artículo científico publicado en 2012

Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption

artículo científico publicado en 2019

Reduced CD161(+) MAIT cell frequencies in HCV and HIV/HCV co-infection: Is the liver the heart of the matter?

artículo científico publicado en 2016

Reduced expression of Blimp-1 in memory B cells in patients with HIV-1 infection suggests distinct roles of this molecule for B and T cell regulation

artículo científico publicado en 2014

Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection

artículo científico publicado en 2008

Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study

artículo científico publicado en 2016

Safety and efficacy of protease inhibitor based combination therapy in a single-center "real-life" cohort of 110 patients with chronic hepatitis C genotype 1 infection

artículo científico publicado en 2014

Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2014

Safety and efficacy of tipranavir co-administered with low-dose ritonavir in patients with advanced HIV-1 infection and limited treatment options

article

Sex differences in infectious diseases and their clinical consequences

artículo científico publicado en 2015

Sex differences in infectious diseases-common but neglected

artículo científico publicado en 2014

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

artículo científico publicado en 2016

Simplification to single-tablet regimen of elvitegravir, cobicistat, emtricitabine, tenofovir DF from multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF regimens: week 96 results of STRATEGY-PI.

artículo científico publicado en 2017

Stereoselective Synthesis of D‐ and L‐Carbocyclic Nucleosides by Enzymatically Catalyzed Kinetic Resolution ⬇️

artículo científico publicado el 24 de julio de 2012

Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease

artículo científico publicado en 2004

Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfection

artículo científico publicado en 2009

The Unenlarged Lymph Nodes of HIV-1–infected, Asymptomatic Patients with High CD4 T Cell Counts Are Sites for Virus Replication and CD4 T Cell Proliferation. The Impact of Highly Active Antiretroviral Therapy ⬇️

artículo científico publicado el 16 de marzo de 1998

The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study

artículo científico publicado en 2001

Transfer of Autologous Gene-modified T Cells in HIV-infected Patients with Advanced Immunodeficiency and Drug-resistant Virus

artículo científico publicado en 2007

Treatment of heavily antiretroviral-experienced HIV-infected patients

artículo científico publicado en 2007

Unsung Hero Robert C. Gallo

artículo científico publicado en 2009

Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon .

artículo científico publicado en 2014

Virological rebound and its consequences during treatment interruption

artículo científico publicado en 2007

[Immune reconstitution inflammatory syndrome in cryptococcal meningitis: a rare phenomenon?]

artículo científico publicado en 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda